The Charles Schwab Corporation $SCHW Shares Bought by Fiduciary ...
π Fiduciary Alliance LLC increased its SCHW holdings by 93.2% to 11,987 shares valued at $1.2 million in Q1.
π Kestra Private Wealth Services LLC dramatically raised its stake by 340.6% to own 41,906 shares worth $3.9 million.
π Institutional ownership of Charles Schwab stands at 84.38% following recent accumulation by hedge funds and wealth advisors.
π° Barclays raised its price objective to $127 with an 'overweight' rating, while Raymond James increased its target to $137.
π UBS Group lowered its price target to $119 but maintained a 'buy' rating on the stock.
π¦ The company maintains a healthy dividend yield of 1.4% with a payout ratio of 25.40% and a PE ratio of 17.93.
πΈ Insiders Nigel Murtagh and Paul Woolway sold shares worth approximately $5.9 million combined in the last ninety days.
π The stock trades below its 200-day simple moving average of $95.21 but above its 50-day moving average of $90.26.
ποΈ Charles Schwab operates with a debt-to-equity ratio of 0.48 and a market capitalization of $157.17 billion.
- Significant accumulation by major institutional investors like Fiduciary Alliance LLC and Kestra Private Wealth Services indicates strong confidence in the company's long-term prospects.
- Multiple top-tier analysts including Barclays, Deutsche Bank, and Raymond James have issued 'buy' or 'overweight' ratings with price targets above current trading levels.
- The company offers a consistent dividend yield of 1.4% with a conservative payout ratio of 25.40%, providing income stability to shareholders.
- Strong institutional ownership at 84.38% suggests the stock is well-supported by professional money managers who view it as a core holding.
- Insider selling activity totaling nearly $5.9 million in the last ninety days, led by executives Nigel Murtagh and Paul Woolway, may signal reduced personal conviction or portfolio rebalancing.
- The stock is currently trading below its 200-day simple moving average of $95.21, which could indicate short-term weakness or a correction from recent highs.
- UBS Group lowered its price target to $119, introducing some divergence in analyst expectations despite the overall bullish consensus.